Profile data is unavailable for this security.
About the company
Hill Incorporated is a progressive bioscience implementation company. It is engaged in building pathways to better and healthier living by leveraging its consumer-packaged goods (CPG) expertise to commercialize technologies to craft cannabis solutions and non-alcoholic beverage products globally. Its Hill Avenue Cannabis business unit is pioneering the space where craft consumer products meet bioscience by combining its CPG commercialization expertise with its rights to use Lexaria Bioscience Corp’s DehydraTECH patent portfolio for product development, licensing and business-to-business (B2B) and business-to-consumer sales of cannabis ingredients or products on a global scale. Its Hill Street Beverages business unit represents its legacy alcohol-free consumer beverage marketing and distribution business. It provides DehydraTECH-enabled B2B solutions for both cannabis extractors and ingredient suppliers and CPG manufacturers whose products are infused with cannabis and or hemp extracts.
- Revenue in CAD (TTM)2.21m
- Net income in CAD-1.62m
- Incorporated2016
- Employees--
- LocationHill Inc2410 Lucknow Drive Unit #31MISSISSAUGA L5S 1V1CanadaCAN
- Phone+1 (647) 241-2609
- Websitehttps://www.hillstreetbeverages.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Aequus Pharmaceuticals Inc | 413.17k | -2.68m | 663.17k | 12.00 | -- | -- | -- | 1.61 | -0.0202 | -0.0202 | 0.0031 | -0.0469 | 0.4071 | 1.36 | 6.12 | -- | -263.64 | -97.96 | -- | -293.31 | 53.45 | -- | -647.61 | -141.53 | 0.0315 | -10.66 | 20.49 | -- | -81.53 | -28.97 | 7.64 | -- | -- | -- |
Hill Inc | 2.21m | -1.62m | 837.11k | -- | -- | 12.11 | -- | 0.3792 | -0.4977 | -0.4977 | 0.677 | 0.0211 | 0.5822 | 11.26 | 4.55 | -- | -42.86 | -56.07 | -48.68 | -70.16 | 60.74 | 53.77 | -73.61 | -106.94 | 1.28 | -5.83 | 0.9749 | -- | -23.45 | 11.51 | 22.89 | -- | -- | -- |
Lumiera Health Inc | 604.19k | -2.41m | 861.63k | -- | -- | -- | -- | 1.43 | -0.0142 | -0.0142 | 0.0036 | -0.0139 | 0.5096 | 2.13 | 11.78 | -- | -202.92 | -- | -- | -- | 13.17 | -- | -398.18 | -- | 0.0395 | -2.10 | -- | -- | 46.91 | -- | -188.58 | -- | -- | -- |
Vitality Products Inc | 766.56k | -153.51k | 1.04m | -- | -- | -- | -- | 1.35 | -0.0037 | -0.0037 | 0.0185 | -0.0345 | 0.9206 | 1.12 | 7.02 | -- | -18.44 | -28.04 | -- | -- | 72.79 | 73.72 | -20.03 | -42.49 | 0.1453 | -- | -- | -- | -4.76 | 8.31 | 49.92 | -- | -0.619 | -- |